Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 2
1975 1
1987 2
1988 4
1989 4
1990 6
1991 2
1992 1
1996 1
1997 3
1999 2
2001 3
2002 2
2003 2
2004 2
2005 3
2006 5
2007 2
2009 1
2010 2
2011 2
2012 4
2014 3
2015 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
Serum electrolyte changes after marathon running.
Rose LI, Carroll DR, Lowe SL, Peterson EW, Cooper KH. Rose LI, et al. Among authors: lowe sl. J Appl Physiol. 1970 Oct;29(4):449-51. doi: 10.1152/jappl.1970.29.4.449. J Appl Physiol. 1970. PMID: 5459911 No abstract available.
The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans.
May PC, Willis BA, Lowe SL, Dean RA, Monk SA, Cocke PJ, Audia JE, Boggs LN, Borders AR, Brier RA, Calligaro DO, Day TA, Ereshefsky L, Erickson JA, Gevorkyan H, Gonzales CR, James DE, Jhee SS, Komjathy SF, Li L, Lindstrom TD, Mathes BM, Martényi F, Sheehan SM, Stout SL, Timm DE, Vaught GM, Watson BM, Winneroski LL, Yang Z, Mergott DJ. May PC, et al. Among authors: lowe sl. J Neurosci. 2015 Jan 21;35(3):1199-210. doi: 10.1523/JNEUROSCI.4129-14.2015. J Neurosci. 2015. PMID: 25609634 Free PMC article. Clinical Trial.
L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI.
Lowe SL, Yeo KP, Teng L, Soon DK, Pan A, Wise SD, Peck RW. Lowe SL, et al. Psychoneuroendocrinology. 2006 May;31(4):473-84. doi: 10.1016/j.psyneuen.2005.11.005. Epub 2005 Dec 27. Psychoneuroendocrinology. 2006. PMID: 16378695 Clinical Trial.
Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human.
Rorick-Kehn LM, Witcher JW, Lowe SL, Gonzales CR, Weller MA, Bell RL, Hart JC, Need AB, McKinzie JH, Statnick MA, Suico JG, McKinzie DL, Tauscher-Wisniewski S, Mitch CH, Stoltz RR, Wong CJ. Rorick-Kehn LM, et al. Among authors: lowe sl. Int J Neuropsychopharmacol. 2014 Oct 31;18(2):pyu036. doi: 10.1093/ijnp/pyu036. Int J Neuropsychopharmacol. 2014. PMID: 25637376 Free PMC article. Clinical Trial.
Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects.
Lowe SL, Wong CJ, Witcher J, Gonzales CR, Dickinson GL, Bell RL, Rorick-Kehn L, Weller M, Stoltz RR, Royalty J, Tauscher-Wisniewski S. Lowe SL, et al. J Clin Pharmacol. 2014 Sep;54(9):968-78. doi: 10.1002/jcph.286. Epub 2014 Mar 26. J Clin Pharmacol. 2014. PMID: 24619932 Clinical Trial.
Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor.
May PC, Dean RA, Lowe SL, Martenyi F, Sheehan SM, Boggs LN, Monk SA, Mathes BM, Mergott DJ, Watson BM, Stout SL, Timm DE, Smith Labell E, Gonzales CR, Nakano M, Jhee SS, Yen M, Ereshefsky L, Lindstrom TD, Calligaro DO, Cocke PJ, Greg Hall D, Friedrich S, Citron M, Audia JE. May PC, et al. Among authors: lowe sl. J Neurosci. 2011 Nov 16;31(46):16507-16. doi: 10.1523/JNEUROSCI.3647-11.2011. J Neurosci. 2011. PMID: 22090477 Free PMC article. Clinical Trial.
Glycolytic enzyme interactions with yeast and skeletal muscle F-actin.
Waingeh VF, Gustafson CD, Kozliak EI, Lowe SL, Knull HR, Thomasson KA. Waingeh VF, et al. Among authors: lowe sl. Biophys J. 2006 Feb 15;90(4):1371-84. doi: 10.1529/biophysj.105.070052. Epub 2005 Dec 2. Biophys J. 2006. PMID: 16326908 Free PMC article.
59 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page